Lck AS A THERAPEUTIC TARGET IN IDIOPATHIC PULMONARY FIBROSIS

摘要

This disclosures provides methods of treatment of idiopathic pulmonary fibrosis (IPF) with an intrabody. Methods of screening for IPF are also provided. Methods for inhibiting fibroblast proliferation, fibroblast differentiation, and/or fibroblast activation of T cells with an intrabody are also provided.